Skip to main content
. 2014 Apr 18;4(1):51–59. doi: 10.1016/j.jceh.2014.04.001

Table 1.

Role of Autophagy in Various Liver Diseases and the Agents Targeting Autophagy.

Liver disease Hepatic autophagy level Role of autophagy Autophagy modulation Agents used to target autophagy
Fatty liver disease Decreased Lipid degradation, insulin signaling Autophagy inducers TORIN-1, Rapamycin
Alcoholic liver disease Decreased Degradation of protein aggregates and damaged organelles Autophagy inducers TORIN-1, Rapamycin
Hepatocellular carcinoma Decreased Anti-tumor effect in normal cells;
Autophagy is used by cancer cells for survival against apoptosis by traditional chemotherapeutic drugs
Autophagy inducers Rapamycin, Everolimus, Bortezomib, Sorafenib, NPC-16,
Autophagy inhibitors 3MA, Chloroquine, SiRNA, MicroRNAs
HBV Infection Increased Autophagy subverted by virus Autophagy suppressor 3MA
Autophagy inducer Rapamycin
HCV infection Increased Autophagy subverted by virus Autophagy suppressor 3MA, Chloroquine
Autophagy inducer Rapamycin
A1-AT deficiency Autophagy clears the AT protein aggregation mTOR independent increase in autophagy Carbamazepine